GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » COGS-to-Revenue

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) COGS-to-Revenue : 0.64 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co COGS-to-Revenue?

Wanbangde Pharmaceutical Holding Group Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥274 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥429 Mil.

Wanbangde Pharmaceutical Holding Group Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.64.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Wanbangde Pharmaceutical Holding Group Co's Gross Margin % for the three months ended in Mar. 2024 was 36.17%.

Wanbangde Pharmaceutical Holding Group Co COGS-to-Revenue Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co COGS-to-Revenue Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 0.90 0.51 0.47 0.59

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.64 0.45 0.64 0.64

Wanbangde Pharmaceutical Holding Group Co COGS-to-Revenue Calculation

Wanbangde Pharmaceutical Holding Group Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=907.265 / 1541.939
=0.59

Wanbangde Pharmaceutical Holding Group Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=273.934 / 429.173
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wanbangde Pharmaceutical Holding Group Co  (SZSE:002082) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Wanbangde Pharmaceutical Holding Group Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 273.934 / 429.173
=36.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Wanbangde Pharmaceutical Holding Group Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » COGS-to-Revenue
Comparable Companies
SZSE:301520 SZSE:300239 SHSE:688073 BJSE:830946 SZSE:002412 SHSE:603168 SZSE:300452 SZSE:301201 SHSE:600594 SZSE:000153 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Website
http://www.wepon.com.cn
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines